clinical_trials
New Trials Back Quickly Approved Drugs for Primary Biliary Cholangitis
Confidence86·multiple reportsImportance88NP-EVT-20261106-4B32188
(MedPage Today) -- Treatment with both elafibranor (Iqirvo) and seladelpar (Livdelzi) led to alkaline phosphatase (ALP) normalization in the vast majority of patients with primary biliary cholangitis (PBC) who had elevated ALP levels after an incomplete...
Read the original at the primary source
New Trials Back Quickly Approved Drugs for Primary Biliary Cholangitis
11/6/2026, 10:16:45 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —